Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: SU011248/Trastuzumab
Sponsor: Pfizer